Prokosch, V.; Dragnea, D. C.; Pitz, S.
Optic disc swelling. A compilation of relevant differential diagnosesOPHTHALMOLOGE. Bd. 113. H. 11. 2016 S. 967-981
Stoffelns, B. M.; Laspas, P.; Roesler, H. -P. et al.
Optical Coherence Tomography (OCT) in Diffuse Choroidal Haemangioma in Sturge-Weber Syndrome Treated with Low Dose Ocular IrradiationKLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE. Bd. 233. H. 4. 2016 S. 527-529
Stoffelns, BM; Laspas, Panagiotis; Schmidberger, H et al.
Optische Kohärenztomographie (OCT) bei perkutaner fraktionierter Strahlentherapie eines diffusen Aderhauthämangioms bei Sturge Weber-SyndromKlinische Monatsblätter für Augenheilkunde. Bd. 233. H. 4. 2016 S. 527-9
Marco, Rodrigo J. de; Thiemann, Theresa; Groneberg, Antonia H. et al.
Optogenetically enhanced pituitary corticotroph cell activity post-stress onset causes rapid organizing effects on behaviourNature Communications. Bd. 7. London: Nature Publishing Group 2016 Art. 12620
Azaripour, A; Willershausen, I; Hassan, M et al.
Oral Hygiene and Dietary Habits in Adolescents with Fixed Orthodontic Appliances: A Cross sectional StudyJ Contemp Dent Pract. Bd. 17. H. 3. 2016 S. 179-183
Grimm, Daniel; Lieb, Jonas; Weyer, Veronika et al.
Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatmentBMC CANCER. Bd. 16. 2016
Koelmel, S.; Kaeberich, A.; Hobohm, L. et al.
Osteopontin (OPN) and its potential role in the pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH)EUROPEAN HEART JOURNAL. Bd. 37. 2016 S. 361-361
Koc, Marcin; Kostrubiec, Maciej; Elikowski, Waldemar et al.
Outcome of patients with right heart thrombi: the Right Heart Thrombi European RegistryEUROPEAN RESPIRATORY JOURNAL. Bd. 47. H. 3. 2016 S. 869-875
Hassel, J.; Forschner, A.; Bluhm, L. et al.
Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP)JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 14. 2016 S. 9-9
Ascierto, P. A.; Del Vecchio, M.; Robert, C. et al.
Overall survival (OS) and safety results from a phase 3 trial of ipilimumab (IPI) at 3 mg/kg vs 10 mg/kg in patients with metastatic melanoma (MEL)ANNALS OF ONCOLOGY. Bd. 27. 2016